These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23642012)

  • 41. Tertiary hyperparathyroidism resistant to cinacalcet treatment.
    Okada M; Tominaga Y; Izumi K; Nobata H; Yamamoto T; Hiramitsu T; Tsujita M; Goto N; Nanmoku K; Watarai T; Uchida K
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():33-7. PubMed ID: 21595850
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial.
    Floege J; Kubo Y; Floege A; Chertow GM; Parfrey PS
    Clin J Am Soc Nephrol; 2015 May; 10(5):800-7. PubMed ID: 25887067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of calcimimetics on long-term outcomes in dialysis patients: literature review and Bayesian meta-analysis.
    Lozano-Ortega G; Waser N; Bensink ME; Goring S; Bennett H; Block GA; Chertow GM; Trotman ML; Cooper K; Levy AR; Belozeroff V
    J Comp Eff Res; 2018 Jul; 7(7):693-707. PubMed ID: 29762046
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU
    J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Kidney and bone update : the 5-year history and future of CKD-MBD. Parathyroidectomy for secondary hyperparathyroidism].
    Tominaga Y
    Clin Calcium; 2012 Jul; 22(7):1083-8. PubMed ID: 22750941
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cinacalcet improves bone density in post-kidney transplant hyperparathyroidism.
    Cho ME; Duan Z; Chamberlain CE; Reynolds JC; Ring MS; Mannon RB
    Transplant Proc; 2010 Nov; 42(9):3554-8. PubMed ID: 21094814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Minimal impact of calcimimetics on the management of hyperparathyroidism in chronic dialysis.
    Brunaud L; Ngueyon Sime W; Filipozzi P; Nomine-Criqui C; Aronova A; Zarnegar R; Kessler M; Frimat L; Ayav C
    Surgery; 2016 Jan; 159(1):183-91. PubMed ID: 26476826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of cinacalcet treatment on vascular arterial stiffness among peritoneal dialysis patients with secondary hyperparathyroidism.
    Chow KM; Szeto CC; Kwan BC; Cheng PM; Pang WF; Leung CB; Li PK
    Nephrology (Carlton); 2014 Jun; 19(6):339-44. PubMed ID: 24589316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Timing of parathyroidectomy for tertiary hyperparathyroidism with end-stage renal disease: A cost-effectiveness analysis.
    McManus C; Oh A; Lee JA; Hur C; Kuo JH
    Surgery; 2021 Jan; 169(1):94-101. PubMed ID: 32732069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: study design and baseline characteristics of the IMPACT SHPT study.
    Ketteler M; Martin KJ; Cozzolino M; Goldsmith D; Sharma A; Khan S; Dumas E; Amdahl M; Marx S; Audhya P
    Nephrol Dial Transplant; 2012 May; 27(5):1942-9. PubMed ID: 21931122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Susantitaphong P; Vadcharavivad S; Susomboon T; Singhan W; Dumrongpisutikul N; Jakchairoongruang K; Eiam-Ong S; Praditpornsilpa K
    Ren Fail; 2019 Nov; 41(1):326-333. PubMed ID: 31014177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trends of elevated parathormone serum titers in hemodialysis patients on intensive therapy for bone disease: a multicenter study.
    Karkar A; Sinha AK; Abdelrahman M; Mushtaque F; Awn NM; Qadi Y; Nassar M; Algareeb A; Taha MI; Abdulkader M; Sabry A; Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2014 Nov; 25(6):1166-77. PubMed ID: 25394432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cinacalcet versus Parathyroidectomy in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation.
    Soliman AR; Maamoun HA; Soliman MA; Darwish H; Elbanna E
    Rom J Intern Med; 2016 Sep; 54(3):184-189. PubMed ID: 27658167
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simultaneous control of PTH and CaxP Is sustained over three years of treatment with cinacalcet HCl.
    Sprague SM; Evenepoel P; Curzi MP; González MT; Husserl FE; Kopyt N; Sterling LR; Mix C; Wong G
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1465-76. PubMed ID: 19696213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Middle-term use of Cinacalcet in paediatric dialysis patients.
    Platt C; Inward C; McGraw M; Dudley J; Tizard J; Burren C; Saleem MA
    Pediatr Nephrol; 2010 Jan; 25(1):143-8. PubMed ID: 19838738
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Randomized Study Comparing Parathyroidectomy with Cinacalcet for Treating Hypercalcemia in Kidney Allograft Recipients with Hyperparathyroidism.
    Cruzado JM; Moreno P; Torregrosa JV; Taco O; Mast R; Gómez-Vaquero C; Polo C; Revuelta I; Francos J; Torras J; García-Barrasa A; Bestard O; Grinyó JM
    J Am Soc Nephrol; 2016 Aug; 27(8):2487-94. PubMed ID: 26647424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
    Block GA; Martin KJ; de Francisco AL; Turner SA; Avram MM; Suranyi MG; Hercz G; Cunningham J; Abu-Alfa AK; Messa P; Coyne DW; Locatelli F; Cohen RM; Evenepoel P; Moe SM; Fournier A; Braun J; McCary LC; Zani VJ; Olson KA; Drüeke TB; Goodman WG
    N Engl J Med; 2004 Apr; 350(15):1516-25. PubMed ID: 15071126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Parathyroidectomy versus Cinacalcet in the Management of Tertiary Hyperparathyroidism: Surgery Improves Renal Transplant Allograft Survival.
    Finnerty BM; Chan TW; Jones G; Khader T; Moore M; Gray KD; Beninato T; Watkins AC; Zarnegar R; Fahey TJ
    Surgery; 2019 Jan; 165(1):129-134. PubMed ID: 30415867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Analysis of the efficacy and factors influencing the response of secondary hyperparathyroidism patients on hemodialysis to cinacalcet].
    Segura Torres P; Borrego Utiel FJ; Sánchez Perales MC; García Cortés MJ; Biechy Baldán MM; Pérez Bañasco V
    Nefrologia; 2010; 30(4):443-51. PubMed ID: 20651886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of cinacalcet on bone mineral density of the radius in hemodialysis patients with secondary hyperparathyroidism.
    Ishimura E; Okuno S; Tsuboniwa N; Ichii M; Yamakawa K; Yamakawa T; Shoji S; Nishizawa Y; Inaba M
    Clin Nephrol; 2011 Oct; 76(4):259-65. PubMed ID: 21955860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.